✨ Free AI Report
MioDottore: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research MioDottore
Company Research

MioDottore: Business Overview, Financials & Competitive Analysis

MioDottore scores 8/10 on the AskCyborg Cyborg Score (Strong). Market-leading healthcare booking platform with unicorn-backed funding, strong unit economics, and clear path to sustained profitability through services and software monetization. MioDottore holds dominant market position in Italy with scale (2.5M monthly bookings, ~300K doctors), backed by a well-funded international parent (Docplanner, unicorn status with €450M+). Strong revenue indicators and strategic.

What is MioDottore's industry? MioDottore (miodottore.com) operates in Healthcare IT Services. AskCyborg classifies MioDottore under Healthcare IT Services in its company registry.

MioDottore, part of the Docplanner group, was born in 2015 in Italy and is the leading digital platform dedicated to private and public healthcare that connects patients with specialist doctors, general practitioners,...

8/ 10Strong

Cyborg Score thesis

Market-leading healthcare booking platform with unicorn-backed funding, strong unit economics, and clear path to sustained...

Read the full analyst-debate transcript →
Industry Healthcare IT Services
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 21, 2026
AI-Verified Research
30+ Page Report

Get the Latest MioDottore Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for MioDottore

AskCyborg analysts argue the bull and bear cases for MioDottore across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
MioDottore OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

MioDottore Overview

Pro stress-test →

MioDottore, part of the Docplanner group, was born in 2015 in Italy and is the leading digital platform dedicated to private and public healthcare that connects patients with specialist doctors, general practitioners, medical centers, and hospitals. The platform enables users to book appointments or consultations online with the best specialists and general practitioners.

Strategic Profile

Pro stress-test →

MioDottore records 2.5 million bookings/month, over 8.5 million monthly visits to the portal, almost 300,000 doctors available on the platform and around 35,000 customers. As of 2015 with a team of 500 people, MioDottore is part of Docplanner group, a main international HealthTech entity, supported by leading VCs like Goldman Sachs, One Peak Partners, Point Nine and Target Global. It is currently a unicorn with over €450M of investments raised.

Competitive Landscape

Pro stress-test →

MioDottore's top competitors include DocPlanner, Doctolib and IDoctors. MioDottore leads in the Italian market through first-mover advantage (founded 2015) and integrated software suite for healthcare providers. Doctolib and similar platforms compete primarily in adjacent European markets, while MioDottore's parent company Docplanner operates globally, creating cross-regional synergies but also internal competition that the company navigates through geographic segmentation.

Industry Context

MioDottore operates in Healthcare IT Services.

Key facts

Founded: 2015 · Headquarters: Milan, Italy · Employees: 634 · Revenue: $16M · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for MioDottore.

  • Dominant Italian market position with 2.5M monthly bookings and 300K+ healthcare professionals on platform
  • Part of Docplanner unicorn group valued at €450M+, operating in 13 countries with 2M+ health professionals globally
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Expanded platform metrics to nearly 300,000 doctors and 35,000 customer accounts as of 2024
  • Continues investment in AI-powered tools for physicians and diagnostic service accessibility across Italian market
  • +1 moreTrack every material event for MioDottore as it happens. Explore monitoring →
Get alerted when MioDottore has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

DoctolibHealthcare booking platform operating across France, Germany, and other European markets→ZocdocUS-focused healthcare booking and provider review platform→PractoAsia-Pacific healthcare platform connecting patients with doctors→

Compare MioDottore with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

MioDottore operates in Healthcare IT Services. See how the rest of the sector scores on the Cyborg framework.

Browse Healthcare IT Services research →
NEW · MCP server

Ask your AI assistant about MioDottore

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare MioDottore and its top competitor on Cyborg Score”
“What did MioDottore do this quarter?”
“Is MioDottore a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does MioDottore do?+
MioDottore, part of the Docplanner group, was born in 2015 in Italy and is the leading digital platform dedicated to private and public healthcare that connects patients with specialist doctors, general practitioners,...
What is MioDottore's Cyborg Score?+
MioDottore has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are MioDottore's main competitors?+
Named competitors include Doctolib, Zocdoc, Practo. The full competitive landscape is in the AskCyborg report.
How can I get the full MioDottore research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the MioDottore research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track MioDottore over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.